Considering CAPA: Maybe It’s Not a Monster After All
It’s time to consider CAPAs as opportunities rather than just other issues to tackle.
Tag Archives: regulatory
The Top Trend for Medical Devices in 2021? Putting Quality First
Moving too quickly in the product development process can lead to mistakes.
The Future of MedTech and Healthcare: No Boundary on Uniting Forces
All industries under the healthcare umbrella should embrace each other’s capabilities because no single category of player can master it and bring to consumers all that we need and demand, says Stephen Bernstein of McDermott Will & Emery.
Managing Testing Strategies Under the EU MDR
Companies can improve their chances for a successful transition by leveraging their knowledge of their medical devices and understanding what each device’s categorization under the MDR means to its testing strategy.
An Intelligent Approach to Modernizing Quality Management Systems
Operating with an antiquated QMS raises your risk. Here’s what to consider when modernizing your system.
Patent and Regulatory Challenges in AI’s Use in Life Sciences
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
Medical Device Cybersecurity Conference to Tackle Critical Legacy Issues
This year’s virtual event features experts from medical device companies, hospitals and government organizations.
Next Week: Emergency Use Authorization Webinar Walks MedTech Companies Through Regulatory Process
Don’t miss this opportunity to learn how your company can effectively push its product to the finish line.
Illuminating the Shadows: How Unveiling Five Blind Spots Can Transform Business
Whatever the short- and longer-term fallout of COVID-19, organizations will need to come back fighting—with new tools at their disposal and ready to raise their game.
Will the 2020 Elections Affect MedTech Investment? Maybe
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
